Overview
Dawn Health has raised €21.5 million in a growth investment round to enhance its AI-enabled patient companion platform for pharmaceutical companies. The funding, led by Cipio Partners alongside existing investors, aims to improve disease management and clinical research while accelerating product development. CEO Alexander Mandix Hansen expressed excitement about the alignment with Cipio's capabilities and the company's vision.
Products
Loading...
Recent Deals
Investors: Cipio Partners
Dawn Health has raised €21.5 million in a growth investment round to enhance its AI-enabled patient companion platform for pharmaceutical companies. The funding, led by Cipio Partners alongside existing investors, aims to improve disease management and clinical research while accelerating product development. CEO Alexander Mandix Hansen expressed excitement about the alignment with Cipio's capabilities and the company's vision.